RxDoctor Payments DataLook up a doctor →

Vijay Ramanath, MD

Interventional Cardiology · Plano, TXNPI 1003841297

Payments from drug & device makers

$438,413in general payments, 2019–2025

Across 1,179 payments — averaging $371.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$193K
  • Novartis$139K
  • Abbott$43K
  • Medtronic$17K
  • Terumo Medical Corporation$8K
  • Penumbra, Inc.$6K
  • plus $33K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific181$192,574
Novartis77$138,703
Abbott63$43,425
Medtronic(2 entities)115$17,087
Terumo Medical Corporation14$7,997
Penumbra, Inc.37$5,693
Angiodynamics, Inc.14$5,570
W. L. Gore & Associates, Inc.17$4,067
Edwards Lifesciences40$3,546
Shockwave Medical, Inc9$3,421
Cardiovascular Systems Inc.8$2,498
Johnson & Johnson86$1,438
Abiomed17$1,351
Amgen84$1,135
Merck52$921
Pfizer51$883
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)33$724
Heartflow, Inc.10$644
E.r. Squibb & Sons, L.L.C.28$492
Medicure Pharma Inc.3$480
AstraZeneca24$475
Amarin Pharma, Inc.27$426
Boehringer Ingelheim18$421
Itamar Medical Inc5$350
Alnylam Pharmaceuticals Inc.14$334
Sanofi-aventis U.S. LLC14$320
Esperion Therapeutics, Inc.17$296
Philips North America LLC5$293
Cleerly, Inc.5$289
Sanofi12$271
Lundbeck LLC14$241
Astellas Pharma US Inc7$204
Inari Medical, Inc.2$182
Recor Medical Inc3$150
Regeneron Healthcare Solutions, Inc.6$148
Novo Nordisk6$147
Tactile Systems Technology Inc8$121
Bridgebio Pharma, Inc.4$115
Scpharmaceuticals Inc.6$112
Bard Peripheral Vascular, Inc.2$91
Kiniksa Pharmaceuticals International, PLC3$78
Kowa Pharmaceuticals America, Inc.4$60
Cvrx, Inc.2$53
Arbor Pharmaceuticals, Inc.3$46
Stryker2$46
Baxter Healthcare1$40
Althera Pharmaceuticals LLC3$39
Chiesi USA, Inc.2$35
Imperative Care, Inc1$31
G Medical Diagnostic Services, Inc.2$28
Davol Inc.1$28
Cardiva Medical, Inc.1$27
Bardy Diagnostics, Inc.2$26
Actelion Pharmaceuticals US, Inc.1$23
Lexicon Pharmaceuticals, Inc.1$23
Bayer1$21
Atricure, Inc.1$20
Medline Industries LP1$19
Azurity Pharmaceuticals, Inc.1$17
Kiniksa Pharmaceuticals, Ltd.1$17

How this compares

$438,413 in reported general payments places this provider in the 90th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas →

Medicare billing

Part B allowed, 2024
$701,594
Medicare patients
1,038
Services billed
4,876

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Plano

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →